The National Institutes of Health (NIH) and Food and Drug Administration (FDA) announced that they have joined forces to create a protocol template to expedite review processes for clinical trials. Many companies welcome a formalized template to follow, but how can they best prepare to adopt this protocol format? The answer lies in creating structure for the information so that the content required can lend itself both to meeting requirements and eventual re-use. Click here for more details.
Clinical Trial Templates – Meet the New Guidelines
Collateral